Results 121 to 130 of about 13,230 (236)

The phase I study of propafenone, a new antiarrhythmic agent.

open access: bronze, 1986
Takao Kato   +11 more
openalex   +2 more sources

Unmasking Effect of Propafenone on the Concealed Form of the Brugada Phenomenon [PDF]

open access: bronze, 2000
Ante Matana   +5 more
openalex   +1 more source

Reduced progression of atrial fibrillation in hypertensive patients with long-term treatment of propafenone

open access: yesКардиоСоматика, 2016
In recent years, progress has been made in the study of the natural history of atrial fibrillation (AF) - that, from the stage of having no clinical manifestations, to the final stage, which is an irreversible arrhythmia, is associated with the ...
A. I Tarzimanova, V. I Podzolkov
doaj  

Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)

open access: yesСучасні медичні технології
Aim: to analyze the pharmacological features and updated evidence-based medicine data of Class IC antiarrhythmic drug (AAD) ethacizine compared to propafenone to optimize the choice of treatment for cardiac arrhythmias in patients without structural ...
N. M. Sydorova, M. Yu. Kolesnyk
doaj   +1 more source

Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants [PDF]

open access: yes, 2018
Amiodarone is an effective anti-arrhythmic agent for the treatment of supraventricular and ventricular tachycardias. The safety and efficacy of intravenous amiodarone has been described in adults and children but only to a limited extent in infants.
Bauersfeld, Urs   +2 more
core  

Depressant actions of propafenone on electrical and contractile activities of single ventricular myocytes

open access: gold, 1986
Toshifumi Watanabe   +4 more
openalex   +1 more source

Ensanchamiento del complejo QRS: ¿hiperkalemia? ¿propafenona?

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2012
RESUMEN La hiperkalemia y la propafenona  son condiciones que enlentecen la velocidad de conducción intracardiaca. Se presenta  una paciente que en el curso de una hiperkalemia moderada y con dosis bajas de propafenona mostró una taquicardia sinusal con
Marleny Cruz Cardentey   +2 more
doaj  

Central blood volume in cirrhosis [PDF]

open access: yes, 1993
Bendtsen, Flemming   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy